| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1-Specific Manner that Requires TAK1 and p38 Mitogen-Activated Protein Kinase
Division of Cardiology (M.R.B., C.S.L.), University of Colorado Health Sciences Center, Cardiology Section (C.S.L.), Denver Health Medical Center, Denver, Colorado 80204
Address all correspondence and requests for reprints to: Carlin S. Long, M.D., 777 Bannock Street, Box 0960, Denver, Colorado 80204. E-mail: clong{at}dhha.org.
Alterations in TR [thyroid hormone (TH) receptor]1 isoform expression have been reported in models of both physiologic and pathologic cardiac hypertrophy as well as in patients with heart failure. In this report, we demonstrate that TH induces hypertrophy as a direct result of binding to the TR
1 isoform and, moreover, that overexpression of TR
1 alone is also associated with a hypertrophic phenotype, even in the absence of ligand. The mechanism of TH and TR
1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor ß-activated kinase (TAK1) and p38. Mitigating TR
1 effects, both TR
2 and TRß1 attenuate TR
1-induced myocardial growth and gene expression by diminishing TAK1 and p38 activities, respectively. These findings refine our previous observations on TR expression in the hypertrophied and failing heart and suggest that manipulation of thyroid hormone signaling in an isoform-specific manner may be a relevant therapeutic target for altering the pathologic myocardial program.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
E. Ortega, J. Koska, N. Pannacciulli, J. C Bunt, and J. Krakoff Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals Eur. J. Endocrinol., February 1, 2008; 158(2): 217 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Irrcher, D. R. Walkinshaw, T. E. Sheehan, and D. A. Hood Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo J Appl Physiol, January 1, 2008; 104(1): 178 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Belke, B. Gloss, E. A. Swanson, and W. H. Dillmann Adeno-Associated Virus-Mediated Expression of Thyroid Hormone Receptor Isoforms-{alpha}1 and -{beta}1 Improves Contractile Function in Pressure Overload-Induced Cardiac Hypertrophy Endocrinology, June 1, 2007; 148(6): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pantos, I. Mourouzis, C. Xinaris, A. D Kokkinos, K. Markakis, A. Dimopoulos, M. Panagiotou, T. Saranteas, G. Kostopanagiotou, and D. V Cokkinos Time-dependent changes in the expression of thyroid hormone receptor {alpha}1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling Eur. J. Endocrinol., April 1, 2007; 156(4): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salem, P. B. Kenney, C. E. Rexroad 3rd, and J. Yao Microarray gene expression analysis in atrophying rainbow trout muscle: a unique nonmammalian muscle degradation model Physiol Genomics, December 13, 2006; 28(1): 33 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kenessey and K. Ojamaa Thyroid Hormone Stimulates Protein Synthesis in the Cardiomyocyte by Activating the Akt-mTOR and p70S6K Pathways J. Biol. Chem., July 28, 2006; 281(30): 20666 - 20672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kenessey, E. A. Sullivan, and K. Ojamaa Nuclear localization of protein kinase C-{alpha} induces thyroid hormone receptor-{alpha}1 expression in the cardiomyocyte Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H381 - H389. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |